NDC50445-0111-01 — INSULIN HUMAN INJECTION

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC50445-0111-01: INSULIN HUMAN INJECTION.

The INSULIN HUMAN INJECTION is a the manufacturer industrial component. Key specifications include administration: SUBCUTANEOUS, special_features: DERIVED FROM PORCINE SOURCE WITH ENZYME ALTERATIONS TO ACHIEVE INSULIN IDENTICAL TO HUMAN INSULIN, raw_material_source: PORCINE INTESTINAL MUCOSA, primary_container_type: VIAL, therapeutic_equivalent: NOT LISTED, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-239-2460, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC50445-0111-01

NSN: 6505-01-239-2460
FSC: 6505 — Drugs and Biologicals
CAGE: 60554 — NOVO NORDISK INC (USA)

SPECIFICATIONS

administration	SUBCUTANEOUS
special_features	DERIVED FROM PORCINE SOURCE WITH ENZYME ALTERATIONS TO ACHIEVE INSULIN IDENTICAL TO HUMAN INSULIN
raw_material_source	PORCINE INTESTINAL MUCOSA
primary_container_type	VIAL
therapeutic_equivalent	NOT LISTED
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
primary_container_content_quantity	10.000 MILLILITERS
active_medicament_medicinal_strength	100.000 UNITS INSULIN PER MILLILITER
NSN	6505-01-239-2460

COMPONENT DIAGRAM

KEY FEATURES

•

THERAPEUTIC EQUIVALENT: NOT LISTED

•

ADMINISTRATION: SUBCUTANEOUS

•

PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: VIAL

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 UNITS INSULIN PER MILLILITER

•

RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA

TECHNICAL CHARACTERISTICS

THERAPEUTIC EQUIVALENT	NOT LISTED
ADMINISTRATION	SUBCUTANEOUS
PRIMARY CONTAINER CONTENT QUANTITY	10.000 MILLILITERS
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	VIAL
SPECIAL FEATURES	DERIVED FROM PORCINE SOURCE WITH ENZYME ALTERATIONS TO ACHIEVE INSULIN IDENTICAL TO HUMAN INSULIN
ACTIVE MEDICAMENT MEDICINAL STRENGTH	100.000 UNITS INSULIN PER MILLILITER
RAW MATERIAL SOURCE	PORCINE INTESTINAL MUCOSA

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 1

VELOSULIN HUMANReference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC50445-0111-01?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC50445-0111-01?

NDC50445-0111-01 is a INSULIN HUMAN INJECTION.

What parts can replace NDC50445-0111-01?

There is 1 known substitute for NDC50445-0111-01: VELOSULIN HUMAN. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC50445-0111-01?

NDC50445-0111-01 is cataloged in the U.S. Government catalog under NSN 6505-01-239-2460. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC50445-0111-01 — INSULIN HUMAN INJECTION

Request a Quote — NDC50445-0111-01